KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Working Capital Changes (2016 - 2025)

Pacira BioSciences has reported Other Working Capital Changes over the past 16 years, most recently at -$12.7 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$12.7 million for Q4 2025, down 98.45% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 2086.89% YoY), and the annual figure for FY2025 was $1.2 million, up 2086.89%.
  • Other Working Capital Changes for Q4 2025 was -$12.7 million at Pacira BioSciences, down from -$4.7 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PCRX hit a ceiling of $11.5 million in Q2 2025 and a floor of -$12.7 million in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was $1.0 million (2021), compared with a mean of $388550.0.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 6762.5% in 2022 and later surged 10600.0% in 2023.
  • Pacira BioSciences' Other Working Capital Changes stood at -$3.8 million in 2021, then surged by 156.33% to $2.1 million in 2022, then crashed by 190.24% to -$1.9 million in 2023, then plummeted by 232.76% to -$6.4 million in 2024, then plummeted by 98.45% to -$12.7 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$12.7 million (Q4 2025), -$4.7 million (Q3 2025), and $11.5 million (Q2 2025) per Business Quant data.